Nasal immunization by (PLGA) nanospheres encapsulated with tetanus toxoid and (CpG-ODN)

Iranian Journal of Pharmaceutical Research

Volumn 6, Issue 3, 2007, Pages 151-158

  Tafaghodi, Mohsen ^a,b   Tabassi, Seyed Abolghasem Sajadi ^a,d   Jaafari, Mahmoud Reza ^a,c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CpG ODN; Nanosphere; Nasal immunization; PLGA; Tetanus toxoid

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; NANOSPHERE; POLYGLACTIN; TETANUS ANTIBODY; TETANUS TOXOID;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; ENCAPSULATION; ERYTHROCYTE; FEASIBILITY STUDY; FEMALE; HEMOLYSIS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MONOTHERAPY; MUCOSAL IMMUNITY; NONHUMAN; NORMAL HUMAN; PARTICLE SIZE; RABBIT; TETANUS; TETANUS PROPHYLAXIS; VOLUNTEER;

EID: 39749093264     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Men Y, Thomasin C, Merkle HP, Gander B and Corradin G. A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide. Vaccine (1995) 13: 683-689
2. Diwan M, Tafaghodi M and Samuel J. Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanosphere. J. Control. Rel. (2002) 85: 247-262.
3. Tafaghodi M, Sajadi Tabasi SA and Jaafari MR. Formulation and characterization and release studies of alginate microsphere encapsulated with tetanus toxoid. J. Biomat. Sci. Polymer Ed. (2006) 17: 909-924
4. Tafaghodi M, Sajadi Tabasi SA and Jaafari MR. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN. Int. J. Pharm. (2006) 319:37-43
5. Sasiak AB, Bolgiano B, Crane DT, Hockley DJ, Corbel MJ and Sesardic D. Comparison of in vitro and in vivo methods to study stability of PLGA microencapsulated tetanus toxoid vaccines. Vaccine (2000) 19: 694-705
6. Jones DH, Corris S, McDonald S, Clegg JCS and Farrar GH. Poly(-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine (1997) 15:814-817
7. Tafaghodi M, Jaafari MR and Sajadi Tabasi SA. Nasal immunization studies by liposomes encapsulated with tetanus toxoid and CpG-ODN. Eur. J. Pharm. Biopharm. (2006) 64: 138-145
8. Eyles JE, Williamson ED and Alpar HO. Immunological responses to nasal delivery of free and encapsulated tetanus toxoid: studies on the effect of vehicle volume. Int. J. Pharm. (1999) 189: 75-79
9. Krieg AM. The role of CpG motifs in innate immunity. Cur. Opin. Immunol. (2000) 12: 35-43
10. McCluskie MJ, Weeratna RD, Krieg AM and Davis HL. CpG DNA is an effective oral adjuvant to protein antigens in mice. Vaccine (2000) 19: 950-957
11. Scheule RK. The role of CpG motifs in immunostimulation and gene therapy. Adv. Drug Deliv. Rev. (2000) 44: 119-134
12. Sparwasser T, Vabulas RM, Villmow B, Lipford GB and Wagner H. Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins. Eur. J. Immunol. (2000) 30:3591-3597
13. Stacey KJ, Sester DF, Sweet MJ and Hume DA. Macrophage activation by immunostimulatory DNA. Cur. Top. Microbiol. Immunol. (2000) 247:41-58
14. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA and Klinman DM. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (1995) 374: 546-549
15. Krieg AM. From A to Z on CpG. Trends Immunol. (2002) 23: 64-65
16. McCluskie MJ and Davis HL. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. J. Immunol. (1998) 161: 4463-4466
17. Moldoveanu Z, Love-Homan L, Huang WQ and Krieg AM. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine (1998) 16: 1216-1224
18. Oxenius A, Martinic MM, Hengartner H and Klenerman P. CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines. J. Virol. (1999) 73: 4120-4126
19. Tafaghodi M, Sajadi Tabassi SA, Jaafari M-R, Zakavi SR and Momen Nejad M. Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy. Int. J. Pharm. (2004) 280: 125-135
20. Barman SP, Lunsford L, Chambers P and Hedley ML. Two methods for quantifying DNA extracted from poly(lactide-co-glycolide) microspheres. J. Control. Rel. (2000) 69: 337-344
21. Dokmetjian J, Della Valle C, Lavigne V, de Lujan CM and Manghi MA. A possible explanation for the discrepancy between ELISA and neutralising antibodies to tetanus toxin. Vaccine (2000) 18: 2698-2703
22. Bjork E and Edman P. Characterization of degradable starch microspheres as a nasal delivery system for drugs. Int. J. Pharm. (1990) 62: 187-192
23. Gursel M, Tunca S, Ozkan M, Ozcengiz G and Alaeddinoglu G. Immunoadjuvant action of plasmid DNA in liposomes. Vaccine (1999) 17: 1376-1383
24. Shirota H, Sano K, Kikuchi T, Tamura G and Shirato K. Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator. J. Immunol. (2000) 164: 5575-5582
25. Alpar HO and Almeida AJ. Identification of some of the physico-chemical characteristics of microspheres which influence the induction the immune response following mucosal delivery. Eur. J. Pharm. Biopharm. (1994) 40: 198-202
26. Stuart BO. Deposition and clearance of inhaled particles. Environ. Health Perspect. (1984) 55: 369-390
27. Payne JM, Sansom BF, Garner RJ, Thomson AR and Miles BJ. Uptake of small resin particles (1-5 micron diameter) by the alimetary canal of the calf. Nature (1960) 188: 586-587
28. Chen KS and Quinnan GV, Jr. Secretory immunoglobulin A antibody response is conserved in aged mice following oral immunization with influenza virus vaccine. J. Gen. Virol. (1989) 70: 3291-3296
29. Eldridge JH, Hammond CJ, Meulbroek JA, Staas JK, Gilley RM and Tice TR. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches. J. Control. Rel. (1990) 11: 205-214
30. Kidane A, Guimond P, Rob Ju T-c, Sanchez M, Gibson J, North A, HogenEsch H and Bowersock TL. Effects of cellulose derivatives and poly(ethylene oxide)-poly(propylene oxide) tri-block copolymers (Pluronic(R)surfactants) on the properties of alginate based microspheres and their interactions with phagocytic cells. J. Control. Rel. (2002) 85: 181-189